Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia

PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study aimed to evaluate the role of decitabine as a first-line treatment for older adults with AML. MATER...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Yonsei Med J
Autori principali: Park, Hyunsung, Chung, Haerim, Lee, Jungyeon, Jang, Jieun, Kim, Yundeok, Kim, Soo Jeong, Kim, Jin Seok, Min, Yoo Hong, Cheong, June-Won
Natura: Artigo
Lingua:Inglês
Pubblicazione: Yonsei University College of Medicine 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122650/
https://ncbi.nlm.nih.gov/pubmed/27873493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.1.35
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi